S100A7 and invasive breast carcinoma: Kaplan-Meier and multivariate analyses of Japanese patients (n = 150) and a public database (n = 3455) also suggested that S100A7 could be an independent marker of poor prognosis for the recurrence of invasive breast carcinoma, but the correlation did not remain significant when the patients were limited to the ER− group.